Brainstorm Cell Therapeut...

NASDAQ: BCLI · Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Aug 15, 2025, 11:13 AM

Brainstorm Cell Therapeutics Revenue

Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending March 31, 2025, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
849K
Revenue Growth
n/a
Price / Sales Ratio
14.2
Revenue / Employee
31.44K
Employees
27
Market Cap
5.9M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.